Browse
You are looking at 21 - 30 of 2,754 items for
- Refine by Content Type: Articles x
Detective Nephron, world-renowned for his expert analytic skills, trains budding physician-detectives in the diagnosis and treatment of kidney diseases. Mackenzie Ula Densa, a budding nephrologist, plans to present a new case to the master consultant.
Recent research suggests a potential expanded role for monitoring of donor-derived cell-free DNA (dd-cfDNA) in the early identification of graft injury after kidney transplantation.
In the Assessing Donor-Derived Cell-Free DNA Monitoring Insights of Kidney Allografts with Longitudinal Surveillance (ADMIRAL) study, published in
Let me dive right in! A traditional business plan equates one full-time equivalent (FTE) to 8 out of 10 half-day sessions of direct clinical work, which expects the physician to complete an average of 12 patient visits in a 4-hour clinic session (a typical visit is 15 minutes for follow-up and 30 minutes for a new patient). There are three recipients of the deliverables during a clinic visit: 1) the recipient of the clinical care is the patient; 2) the recipient of the professional billing is the practice plan; and 3) the recipient of most of the
As a family physician and diabetes team lead in Juneau working for the Southeast Alaska Regional Health Consortium, Mary Owen, MD, could audit the care received by all of the diabetes patients served by her tribal clinic. The Special Diabetes Program for Indians (SDPI) funded this population-based approach through the Indian Health Service (IHS), which contracted with the clinic.
The audits allowed Owen, now director of the Center of American Indian and Minority Health at the University of Minnesota Medical School, to assess blood pressure and blood sugar control among patients and to gauge how many patients were receiving guideline-directed
The American Kidney Fund (AKF) has awarded its 2022 Clinical Scientist in Nephrology Program fellowships to two deserving researchers: Jillian Caldwell, DO, a nephrology fellow with Stanford University School of Medicine, and Janewit Wongboonsin, MD, MS, a clinical and research fellow with the Brigham and Women's Hospital (BWH)-Massachusetts General Hospital (MGH) Renal Fellowship Program, conducting his postdoctoral research at Boston Children's Hospital (BCH).
Modality selection for treatment of end stage kidney disease (ESKD) is a complex, life-changing decision that patients with chronic kidney disease (CKD) must address. Offering conservative, or non-dialysis therapy, as an option continues to be a challenge for nephrologists. Conversations to discuss this option are held infrequently, due to prognostic uncertainty, a lack of an organizational care framework, and significant emotional attachments (
Physicians tend to overestimate their communication
In oncology, survivorship focuses on the health and well-being of a person with cancer from the time of diagnosis until the end of life (
The field of onconephrology has recently begun to take shape, and thus, education aimed at onconephrology is still evolving. Importantly, onconephrology was galvanized in the age of social media; thus, non-traditional media is playing a pivotal role in shaping education in onconephrology. For example, the American Society of Onconephrology (ASON) was largely materialized by a group of nephrologists all over the world using WhatsApp to discuss and share cases and forge research collaborations.
The first textbook devoted solely to onconephrology topics was published in 2005 (
Page charges have been in existence across many fields of science for a century or longer, and journals have to cover their costs. Historically, journals have relied on income from subscriptions to cover costs associated with printing, distribution, and other overhead fees, whereas peer review and editorial board activities were free. The funding model for such journals has now undergone unprecedented change. Originally, many journals transitioned gradually into an online-only, paywall-protected existence, as both institutional and individual subscriptions declined. As a result of this development, many researchers and clinicians in low- and middle-income countries lost access to published research or
Latin America is a vast region of primarily middle- and low-income countries with approximately 660 million people who share a Latin extraction and language (Spanish or Portuguese). The area exhibits extreme diversity in socioeconomic status and access to quality health care. The prevalence of chronic kidney disease (CKD) seems to be growing in Latin America (
